Campaign details
Advertiser: AMAG PharmaceuticalsAgency: Marina Maher Communications
New product, crowded field and you're ready for your close up.
Last November, the FDA approved AMAG Pharmaceuticals' INTRAROSA (prasterone) a novel treatment for moderate to severe pain during intercourse occurring in women due to menopause. While INTRAROSA has significant benefits versus other treatments – it is a local, non-estrogen steroid without a black box warning – awareness was low. We needed to markedly increase prescriber mindshare by the time it became commercially available in July, 2017 to make it competitive with established, heavily marketed products.
We chose the...